scPharmaceuticals (SCPH) Insider Trading & Ownership $2.78 -0.26 (-8.55%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$2.90 +0.13 (+4.50%) As of 03/28/2025 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock scPharmaceuticals (NASDAQ:SCPH) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.52%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$4.00 MNumber OfInsiders Selling(Last 3 Years)4Amount OfInsider Selling(Last 3 Years)$3.99 M Get SCPH Insider Trade Alerts Want to know when executives and insiders are buying or selling scPharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SCPH Insider Buying and Selling by Quarter Remove Ads scPharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/25/2022Orbimed Advisors LlcMajor ShareholderBuy762,380$5.25$4,002,495.00 10/10/20225Am Partners Iv, LlcMajor ShareholderSell562,466$4.09$2,300,485.94 10/6/20225Am Partners Iv, LlcMajor ShareholderSell37,534$5.02$188,420.68 9/6/20225Am Partners Iv, LlcMajor ShareholderSell26,622$5.52$146,953.44 4/11/20225Am Partners Iv, LlcMajor ShareholderSell270,000$5.00$1,350,000.00 (Data available from 1/1/2013 forward) SCPH Insider Trading Activity - Frequently Asked Questions Who is on scPharmaceuticals's Insider Roster? The list of insiders at scPharmaceuticals includes 5Am Partners Iv, Llc, and Orbimed Advisors Llc. Learn more on insiders at SCPH. What percentage of scPharmaceuticals stock is owned by insiders? 5.52% of scPharmaceuticals stock is owned by insiders. Learn more on SCPH's insider holdings. scPharmaceuticals Key ExecutivesMr. John H. Tucker (Age 61)President, CEO, Principal Executive Officer & Director Compensation: $981.56kMs. Rachael Nokes (Age 49)Chief Financial Officer Compensation: $573.8kMr. Michael D. HassmanSenior Vice President of Technical OperationsKatherine TaudvinVice President of Corporate Affairs & Human ResourcesDr. John Mohr Pharm.D.Senior Vice President of Clinical Development & Medical AffairsSteve ParsonsSenior Vice President of Commercial More Insider Trading Tools from MarketBeat Related Companies Dianthus Therapeutics Insider Trades Kura Oncology Insider Trades ChromaDex Insider Trades KalVista Pharmaceuticals Insider Trades MeiraGTx Insider Trades Arvinas Insider Trades AnaptysBio Insider Trades Maravai LifeSciences Insider Trades UroGen Pharma Insider Trades Sana Biotechnology Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NASDAQ:SCPH) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding scPharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share scPharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
